Objectives: to evaluate the influence of homologous blood transfusion on immune responses and post-operative morbidity in aortic surgery. Design: analysis of the effects of homologous blood transfusion in 128 patients in a prospective randomised trial evaluating homologous and autologous blood transfusion in aortic surgery. Materials and methods: blood sampled before and at five times after surgery was assayed for C-reactive protein (CRP), neutrophil elastase, TNF-and IL-6. Transfusions, morbidity and mortality were recorded; factors associated with poor outcome were identified by logistic regression. Results: homologous transfusion during surgery was required in 32 patients and precipitated an increase in neutrophil elastase (p=0.008) and TNF-(p=0.015) but not IL-6 and CRP. Elastase peaked early in transfused patients at 41.27 (13.92-52.11) ng/ml by 2 h compared to a peak of 21.51 (10.64-31.13) ng/ml by 24 h in those who were not transfused. TNF-peaked at 1.2 (0-4.33) pg/ml by wound closure in transfused patients and at −0.1 (−2.05-2.52) pg/ml by 2 h without transfusion. Intra-operative homologous transfusion was associated with increased mortality (p=0.01) and prolonged intensive care stay (p=0.03). Mortality increased with age (p=0.003) and was inversely related to the CRP peak (p=0.007). Prolonged surgery predicted post-operative complications (p=0.025). Conclusion: homologous transfusion increased the inflammatory response to aortic surgery and was associated with mortality.
tion. 2, 5, 6 Immuno-suppression due to homologous Introduction blood may influence postoperative infection rates, prognosis in cancer and transplant rejection. 7-12 The Elective surgery accounts for over 40% of all stored precise mechanism of these immune effects has yet to blood transfusions and an even greater proportion of be characterised but may be mediated by both cellular cross-match requests. 1 Blood transfusion is life saving and humoral components. 13 in severe haemorrhage, following trauma or as a com-Autologous blood transfusion may avoid the implication of surgery and its benefits in these indications muno-suppression associated with homologous transare undisputed. However, homologous blood transfusion. A number of studies reported marked fusion was introduced before randomised clinical trials reductions in hospital infection rates, antibiotic usage were widely adopted and its risks are only now being and even length of hospital stay in patients offered quantified. Homologous transfusion may induce a autologous transfusion. [14] [15] [16] However, these studies number of changes within the immune system, causing were either not randomised, were retrospective or immuno-suppression and contributing to infectious the numbers of patients involved were inadequate to complications. [2] [3] [4] Homologous blood has also been asinfluence transfusion policy. In a meta-analysis of sociated with a variety of transfusion reactions, graftseven clinical trials on 1060 patients, the risk of postversus host disease, allo-immunisation, the transoperative infection was 2.37 times greater for patients mission of infectious agents, and immunomodulareceiving homologous blood. 12 We investigated the effect of homologous blood * Please address all correspondence to: S. Haynes, Academic Surgery transfusion on inflammatory response and clinical out- trial comparing two different blood transfusion strat-Transfusion triggers egies: autologous versus homologous transfusion when necessary. The main clinical findings of this trial Homologous blood was administered when the haemoglobin concentration fell below 80 g/L, unless have been reported elsewhere. 17 We now report the results in relation to intraoperative homologous blood salvaged red cells were available. Intraoperatively, transfusion could also be administered when abnormal transfusion requirement.
vital signs or ischaemic electrocardiographic changes persisted after correction of hypovolaemia or in case of severe haemorrhage.
Materials and Methods

Patients
Autologous transfusion Following ethical approval and fully informed consent, 128 patients were randomised to either autologous Patients randomised to autologous transfusion underwent acute normovolaemic haemodilution after in-(acute normovolaemic haemodilution and intraoperative cell salvage, n=65) or homologous (n=63) duction of anaesthesia and immediately before surgery. The amount of blood removed was based transfusion before elective aortic surgery from June 1997 to July 1999. Table 1 describes the inclusion on the preoperative haemoglobin concentration and estimated blood volume calculated from published and exclusion criteria. There were eight participating hospitals but randomisation was central, by computer nomograms, aiming for a post-haemodilution haemoglobin of 105-110 g/L. 18, 19 Cell salvage was by cent-in the Vascular Studies Unit at South Manchester University Hospital. Allocation was stratified using rifugal devices (Cell saver 5, Haemonetics, U.K. or Brat 2, Cobe Laboratories, U.K.). All autologous blood minimisation for (i) hospital, (ii) aortic disease (aneurysm or occlusive), (iii) anti-platelet or anti-co-was re-infused within 6 h of collection. agulant drugs and (iv) estimated blood volume.
Inflammatory mediators Anaesthetic technique
Peripheral venous blood was sampled into standard serum and EDTA blood tubes at six time points: (i) Standard general anaesthetic techniques were used with intravenous induction, endotracheal intubation preoperatively, and postoperatively at (ii) wound closure, (iii) 2 h, (iv) day one, (v) day two and (vi) day and intermittent positive pressure ventilation. Maintenance of anaesthesia was by either an intravenous seven. This was immediately centrifuged at 1300 g for 10 min and plasma/serum samples transferred to or a volatile agent with intraoperative fluids limited to crystalloids where possible. Colloids were avoided −80°C storage for subsequent analysis. C-reactive protein (CRP) was analysed by a standard tur-due to their possible effect on the acute phase response. Epidural anaesthesia with local anaesthetic drugs was bidometric procedure (Dako, Nycomed, Ely, U.K.).
Plasma samples were used to assess neutrophil elastase delayed to the postoperative period to avoid expanding the intravascular volume, causing further using an "in house" enzyme-linked immunosorbent assay, according to the method of Brower and Harpel. 20 haemodilution. IL-6 and TNF-were measured in serum samples using Transfusion commercially available paired antibodies (Biosource, Lifescreen Ltd, Harefield, U.K.). Assays were op-Thirty-two patients required intraoperative transfusion of a median (IQR) of 2 (2-4) homologous units. timised for serum samples to ensure reproducibility and were sensitive to cytokine concentrations lower One-hundred-and-fourteen of the 119 transfusions were buffy coat poor red cell units and the remaining than 5 pg/ml. five were whole blood units. Transfused patients had a significantly higher median (IQR) blood loss of 1742 (1102-2825) ml compared to 800 (580-1169) ml Statistical analysis (p<0.001) as estimated by blood lost to suction and swab weight. They also received more intravenous As all continuous variables were skewed, the Mannfluids during surgery at a median (IQR) of 4450 Whitney U-test was used. The chi-squared test, with (3750-5075) ml compared to 3500 (3000-4500) ml in the Yates correction where appropriate, was used for patients who were not transfused (p<0.001). Ranproportions. To avoid multiple comparisons at difdomisation to "autologous" reduced the need for hoferent time points mediator concentration changes mologous blood during surgery from 25/63 (40%) to were summarised calculating the area under the curve 7/65 (11%) (p<0.001). (AUCs) for each subject. Correlations were calculated using the Spearman rank correlation coefficient. Backward stepwise multiple logistic regression was used to identify predictors of mortality, morbidity and post-Clinical outcome operative infection. Co-variates in this analysis were peaks of mediators concentration, number of pre-Mortality and morbidity for the duration of the inoperative co-morbidities (cardiac disease, respiratory patient stay are summarised in Table 3 . Intensive care disease, hypertension and diabetes), age, aortic disease was required more frequently for transfused patients, (aneurysm or occlusive), transfusion strategy (auwith a median intensive care unit stay (IQR) of 1 (1-2) tologous or homologous), blood loss, operating time days compared to 1 (1-1) days in patients who were and number of homologous units transfused during not transfused (p=0.03). surgery. In this analysis, continuous variables were categorised around the median value.
Inflammatory mediators Results
As expected, there was a marked inflammatory response to surgery, and this was enhanced by intra-The study population was typical of any cohort of patients undergoing aortic surgery (Table 2) . operative transfusion. The rise in neutrophil elastase was more pronounced in patients requiring intra-was 165 (102-194) mg/L in "autologous" and 165 (111-227) mg/L in "homologous" patients. operative transfusion, with an earlier median (IQR) peak at 2 h of 80 (67-94) ng/ml compared to 58 (44-72) ng/ml. The volume of blood transfused during surgery correlated with the rise in neutrophil elastase Predictors of poor outcome at wound closure (r=0.26, p=0.005) and at 2 h (r= 0.31, p=0.001). Neutrophil elastase remained elevated Multiple logistic regression (Table 4) identified opfor a week after surgery in transfused cases, with erating time >150 min as the only independent prea median (IQR) concentration of 65 (41-88) ng/ml dictor of postoperative complications (p=0.025). compared to 46 (40-63) ng/ml in non-transfused Prolonged surgery (>150 min) also had a weak repatients a week following surgery. TNF-increased lationship with postoperative infections, with an OR to a median (IQR) 5 (3-13) pg/ml at wound closure (95% CI)=1.5 (0.65-3.66) (p=0.06). The volume of following transfusion but, despite the insult of aortic intraoperative homologous transfusion in units was surgery, did not rise substantially without transfusion. independently related to mortality on regression (p= The rise in TNF-at wound closure also correlated 0.03). Other predictors of mortality were age (p=0.003) with the volume of homologous blood transfused (r= and a CRP peak <158 mg/L (p=0.007). The median 0.4; p<0.001). Median TNF-concentration fell below (IQR) CRP concentration at 48 h in patients who subbaseline in most patients after the first postoperative sequently died was 124 (0-185) mg/L compared to 173 day, regardless of transfusion. The IL-6 peak tended (136-212) mg/L in survivors (p=0.01). Preoperative to occur earlier at 55 (24-164) pg/ml at 2 h in those co-morbidities, blood loss, aortic disease, ranrequiring homologous blood during surgery, comdomisation to either transfusion strategy, neutrophil pared to 45 (20-112) pg/ml at 24 h in those not transelastase, TNF-and IL-6 did not predict clinical outfused. IL-6 returned towards normal by day two. CRP come. trends were similar in the two groups, with peaks at 48 h of 178 (132-228) and 162 (102-200) mg/L in transfused and non-transfused patients respectively. Median CRP concentration returned to baseline on Discussion day seven in both groups.
Randomisation to autologous transfusion had no Elective aortic reconstruction generated a profound inflammatory response, amplified by intra-operative significant influence on the concentration of neutrophil elastase (p=0.67), TNF-(p=0.34), IL-6 (p=0.21) or transfusion of stored blood. Exposure to homologous blood increased intensive care stays and, after ad-CRP (p=0.4). TNF-peaked at 2 h at 6 (3-17) pg/ml in "autologous" and 5 (2-14) pg/ml in "homologous" justment for confounding variables, mortality. No statistically significant influence of transfusion on patients. The neutrophil elastase peak at day 1 was 66 (53-97) ng/ml in "autologous" and 63 (50-80) ng/ml postoperative infection was detected in these patients undergoing clean surgery. in "homologous". IL-6 also reached its highest concentration 24 h following surgery at 73 (24-157) pg/ Previous work has shown that TNF-and IL-6 rise in response to surgical trauma 21 and that, in ischaemia-ml in "autologous" and 47 (19-127) pg/ml in the "homologous" group. CRP peaked later, at 2 days, and reperfusion injury, TNF-may mediate neutrophil accumulation and priming, with levels rising after aortic cross-clamping and falling quickly after clamp removal. 22 Large increases in TNF-have been associated with severe complications such as multi-organ failure, 23 but this finding was not confirmed by our data. In general TNF-levels were not greatly increased in our elective surgery patients with many assays at the lower limit of sensitivity. Greater rises may have occurred transiently during surgery, recovering by the time blood was sampled after surgery. Elevated postoperative TNF-was associated with intraoperative homologous transfusion but there was no significant correlation between TNF-and morbidity.
IL-6 is a marker of tissue injury and systemic IL-6 responses reflect the severity of surgery. [24] [25] [26] We demonstrated an IL-6 peak within the first 24 h after surgery and a sharp fall over the next two days, which is consistent with previous reports. 27 IL-6 is thought to play a role in the induction of CRP synthesis: CRP peaked 24 h following the IL-6 response, but neither mediator was significantly influenced by homologous transfusion.
Increased neutrophil elastase following surgery has been related to postoperative complications and may reflect the overall immune response. 28 This increase was greater in our transfused patients but did not predict poor outcome. Neutrophil elastase and TNFconcentrations are known to be increased in stored blood. 28, 29 The increases we measured following surgery were related to the volume of homologous blood given during surgery and may be partly explained by the direct infusion of mediators.
Recently, homologous transfusion has been associated with increased postoperative mortality in colorectal, 30 pulmonary 31 and biliary 32 surgery. This association has not been reported in aortic surgery. In our multivariate model, we included measures of patient fitness (age, co-morbidities) and severity of surgery (aortic disease, blood loss, operating time) to verify this association. Although our results confirm a direct relationship between intraoperative transfusion and mortality, it remains impossible to distinguish entirely the effect of transfusion from the effect of the clinical conditions leading to transfusion. Mortality in this study was also suprisingly high, with significant variation among participating centres. This would tend to reduce our ability to detect effects due to blood 
